References
- Ashani Y, Rothshild N, Segall Y, Levanon D, Raveh L. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compound in mice. Life Sci 1991;49:367–374.
- Broomfield CA. A purified recombinant phosphotriesterase protects mice against soman. Physiol Toxicol 1992;70:65–66.
- Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 1988;85:6949–6953.
- Gregoriadis G, Florence AT. Liposomes in drug delivery: clinical, diagnostic, and ophthalmic potential. Drugs 1993;45:15–28.
- Marsh D. Electron spin resonance: spin labels. In: Grell E, (Ed.), Molecular Biology Biochemistry and Biophysics, Membrane Spectroscopy 1981; (pp 51–142 ). Berlin, Germany: Springer.
- Pei L, Petrikovics I, Way JL. Antagonism of the lethal effect of paraoxon by carrier erythrocytes containing organophosphorous acid anhydrase. Fundam Appl Toxicol 1994;28:209–214.
- Petrikovics I, Hong K, Omburo G, Hu QZ, Pei L, McGuinn WD, Sylvester D, Tamulinas C, Papahadjopoulos D, Jaszberenyi JC, Way JL. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. Toxicol Appl Pharmacol 1999;156:56–63.
- Petrikovics I, McGuinn WD, Sylvester D, Yuzapavik P, Jiang J, Way JL, Papahadjopoulos D, Hong K, Jin R, Cheng TC, Defrank JJ. In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. Drug Deliv 2000;7:83–89.
- Rosenson RS, McCormick A, Uretz EF. Distribution of blood viscosity values and biochemical correlates in healthy adults. Clin Chem 1996;42:1189–1195.
- Senior J, Delgado D, Fisher D, Tilcock D, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethyleneglycol)-coated vesicles. Biochem Biophys Acta 1991;1062:77–82.
- Sogorb MA, Díaz-Alejo N, Escudero MA, Vilanova E. Phosphotriesterase activity identified in purified serum albumins. Arch Toxicol 1998;72:219–226.
- Szabó ZS, Budai M, Blaskó K, Gróf P. Molecular dynamics of the cyclic lipodepsipeptides’ action on model membranes: effects of syringopeptin22A, syringomycin E, and syringotoxin studied by EPR technique. BBA Biomembr 2004;1660:118–130.
- Takeuchi H, Kojima H, Yamamoto H, Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Contr Rel 2001;75:83–91.
- Torchilin VP. Immobilized enzymes as drugs. Adv Drug Del Rew 1988;1:270.
- Torchilin VP, Papisov ML. Why do polyethylene glycol coated liposomes circulate so long? J Liposome Res 1994;4:725–739.
- Torchilin VP, Trubetskoy VS, Milshteyn AM, Canillo J, Wolf GL, Papisov MI, Bogdanov A, Narula J, Khaw BA, Omelyanenko VG. Targeted delivery of diagnostic agents by surface- modified liposomes. J Contr Rel 1994;28:45–58.
- Walde P, Ichikawa S. Enzymes inside lipid vesicles: preparation, reactivity, and applications. Biomol Eng 2001;18:143–177.
- Way JL. Spectrophotometric determination of paraoxonase within mouse carrier erythrocytes. Biochem Appl Biotechnol 1994;20:34–41.
- Zhao L, Feng SS, Kocherginsky N, Kostetski I. DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. Int J Pharm 2007;338:258–266.